Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug duo aims to shield kidneys in type 1 diabetes

NCT ID NCT06072326

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 24 times

Summary

This study tests whether combining two drugs, dapagliflozin and SC0062, can better protect the kidneys in adults with type 1 diabetes and chronic kidney disease. The trial will involve 36 participants who will try each drug alone and together in a random order. The goal is to see if the combination reduces protein in urine and prevents fluid buildup, without causing serious side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS WITH DIABETIC NEPHROPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam University Academic Center

    Amsterdam, North Holland, 1081 HV, Netherlands

    Contact

  • Regionshospitalet Gødstrup

    Herning, 7400, Denmark

    Contact

  • Steno Diabetes Center Aarhus

    Aarhus, 8200, Denmark

    Contact

  • Steno Diabetes Center Copenhagen

    Copenhagen, 2730 Herlev, Denmark

    Contact

  • Turku University Hospital

    Turku, 20520, Finland

    Contact

  • University Medical Center Groningen

    Groningen, Provincie Groningen, 9700 RB, Netherlands

    Contact

  • University of Helsinki

    Helsinki, Uusimaa, 00029 HUS, Finland

    Contact

Conditions

Explore the condition pages connected to this study.